Ischemic Stroke Device(s)
Ischemic Stroke
Pre-clinicalActive
Key Facts
About Infinity Neuro
Infinity Neuro is a pre-revenue, private neurovascular device company founded in 2020, targeting the large and growing stroke intervention market. The company's strategy is built on a leadership team with extensive, proven experience in bringing neurovascular devices from development through regulatory approval and successful commercial launch. While specific pipeline details are not publicly disclosed, the company's focus is on 'next-level' innovative devices for both ischemic (clot retrieval) and hemorrhagic (brain bleed) stroke, indicating a broad approach to the neurovascular space. Its established relationships with key physician and business professionals worldwide are cited as a core asset for future growth.
View full company profileTherapeutic Areas
Other Ischemic Stroke Drugs
| Drug | Company | Phase |
|---|---|---|
| itMSCs + itNSCs | Stemedica Cell Technologies | Research |
| Ischemic Stroke Program | CHS Pharma | Pre-clinical |
| 3K3A-APC | ZZ Biotech | Phase 2/3 |